Table 2.
Stage* |
5-yr survival† |
Relapse
|
Stage
|
|||||
---|---|---|---|---|---|---|---|---|
Risk of relapse | TN | MAC | OS(%) | DFS(%) | Local(%) | Distant(%) | Dukes | TNM |
Low‡ | T1N0 | A | ~90 | ~90 | ≤ 5 | ~10 | A | I |
T2N0 | B1 | ~90 | ~90 | ≤ 5 | ~10 | A | I | |
Intermediate | T1-2N1 | C1 | 81 | 74 | 6 | 15 | C | IIIA |
T3N0 | B2 | 74 | 66 | 8 | 19 | B | IIA | |
Moderately high | T1-2N2 | C1 | 69 | 62 | 8 | 26 | C | IIIC |
T4N0 | B3 | 65 | 54 | 15 | 28 | B | IIB | |
T3N1 | C2 | 61 | 50 | 11 | 34 | C | IIIB | |
High | T3N2 | C2 | 48 | 39 | 15 | 45 | C | IIIC |
T4N1 | C3 | 33 | 30 | 22 | 39 | C | IIIB | |
T4N2 | C3 | 38 | 30 | 19 | 50 | C | IIIC |
Modified from Gunderson et al.11
Stage of disease based on surgical and pathologic findings at the time of resection
Survival: Unadjusted Kaplan-Meier estimates
Data derived from prior publications, as low-risk patients were not eligible for the three phase III trials in the pooled analysis
Abbreviations: DFS = disease-free survival; MAC = modified Aster-Coller; OS = overall survival; TNM = tumor, node, metastasis.